Global Artificial Intelligence AI In Clinical Trials Market Report 2024

Artificial Intelligence (AI) In Clinical Trials Global Market Report 2024 – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Application (Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications), By End-User (Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $4000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Artificial Intelligence (AI) In Clinical Trials Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Artificial Intelligence (Ai) In Clinical Trials Market Definition And Segments

Artificial intelligence in clinical trials refers to using artificial intelligence to design more efficient and adequate clinical trials. Artificial intelligence is used in clinical trials to improve trial design and optimization through predictions about patient behavior and drug efficacy.

The main offerings of artificial intelligence (AI) in clinical trials are software and services. Software solutions refer to a type of custom-built or configured solution to solve a problem, and artificial intelligence software is used to enable faster and more accurate hypothesis generation and to understand the evolution of a disease. They are applied for various processes such as trial design, patient selection, site selection, and patient monitoring in oncology, neurological diseases and conditions, cardiovascular diseases, metabolic diseases, infectious diseases, immunology diseases, and others. It is used by pharmaceutical and biotechnology companies, contract research organizations, and others.

The artificial intelligence (AI) in clinical trials market covered in this report is segmented –

1) By Offering: Software, Services

2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring

3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users

The artificial intelligence (AI) in clinical trials market size has grown exponentially in recent years. It will grow from $1.52 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches.

The artificial intelligence (AI) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $4.86 billion in 2028 at a compound annual growth rate (CAGR) of 25.6%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (NLP) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes.

Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth

The growing need to curb clinical trial costs is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Clinical trials refer to research studies used to test medical, surgical, or behavioral intervention in people, and the costs of clinical trials include the cost of the research and the cost of patient care. Drug development and other clinical trial processes are costly by nature, and artificial intelligence is used to provide better drug discovery, better designed and safer clinical trials, and improved patient outcomes at lower costs. For instance, in February 2023, according to Genetic Engineering and Biotechnology News, a US-based platform that provides the latest information on genetic engineering and biotechnology, developing a new drug among the top 20 global biopharma companies rose by 15% from $298 million in 2022 to approximately $2.3 billion in 2023, and this includes the costs incurred from developing a drug through clinical trials. Furthermore, in January 2023, according to a report published by the National Bureau of Economic Research (NBER), a US-based non-profit economic research organization, the adoption of AI within the next five years is expected to generate substantial cost savings in healthcare, ranging from 5 to 10% of healthcare spending, equating to approximately $200 billion to $360 billion in annual savings. Therefore, the growing need to curb clinical trial costs will drive artificial intelligence in the clinical trial market.

Surge In Research And Development Activities Propels The Growth Of Artificial Intelligence In The Clinical Trial Market

The increasing number of research and development activities is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Research and Development (R&D) activities refer to the systematic process of investigation, experimentation, and innovation conducted by organizations or individuals to create new products, processes, or knowledge. Artificial Intelligence (AI) plays a significant role in enhancing various aspects of research and development (R&D) activities in the context of clinical trials such as analyzing diverse datasets, implementation of adaptive trial designs, streamlining administrative processes, and others. For instance, in May 2023, according to Xtalks, a Canada-based company providing digital media formats portfolio, the R&D pipeline for drugs saw an increase from 18,582 in 2021 to over 20,109 drugs in 2022. Additionally, in 2023, the global count of registered clinical trials has surged to 452,604, marking a substantial rise from the reported figure of over 365,000 trials in 2021. Therefore, the increasing number of research and development activities will drive artificial intelligence in the clinical trial market.

Major companies operating in the artificial intelligence (AI) in clinical trials market report are Medable Inc., PathAI inc., Saama Technologies Inc., Apellis Pharmaceuticals Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.

Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market

Innovative product offerings are a key trend in artificial intelligence in the clinical trial market. Major companies in the artificial intelligence in clinical trials market have introduced innovative product offerings to sustain their position in the market. For instance, in January 2023, Elligo Health Research Inc., a US-based healthcare-enabling research organization, launched DataAI Connect, an innovative data and technology platform that enables rapid, data-driven clinical research. The platform effortlessly gathers, manages, evaluates, and shares real-world patient data, presenting a comprehensive strategy to overcome clinical trial obstacles instead of acting as an accessory technology. This adaptable and sustainable platform includes an all-in-one solution for retrieving and evaluating medical records. It adeptly transforms data into practical insights and individual patient progress information, leveraging cutting-edge technologies such as NLP, ML, and clinical acumen.

Industry Players Embraces AI Feasibility And Recruitment Platforms To Redefine Artificial Intelligence In Clinical Trials Market

Major companies operating in the artificial intelligence in clinical trials market are focusing on development of innovative technologies such as AI feasibility and recruitment platforms. AI feasibility and recruitment platforms are tools or systems that leverage artificial intelligence (AI) to assess the viability and potential success of clinical trials while also assisting in the efficient recruitment of suitable participants. For instance, in June 2023, a US-based research provider company, announced the launch of ‘ObjectiveScreen’. It is an AI-powered feasibility and recruitment platform that enhances clinical trial performance and results by improving patient identification, prequalification, and retention processes. ObjectiveScreen enables direct connectivity between clinical trial sites and electronic health records (EHRs) of patients. The AI platform promotes patient engagement by simplifying and streamlining appointment scheduling and communication processes.

Paradigm Health Expands Horizons With Strategic Acquisition Of Deep Lens Inc.

In January 2023, Paradigm Health Inc., a US-based healthcare technology company, acquired Deep Lens Inc. for an undisclosed amount. The acquisition aims to provide Paradigm with Deep Lens's platform, which enables equal access to trials for all patients while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Deep Lens Inc. is a US-based provider of an AI-driven cloud platform for clinical research.

North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence (AI) in clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in clinical trials market consists of revenues earned by entities by providing artificial intelligence in clinical trials services that include data security and compliance services and consulting and implementation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the clinical trials market also includes sales of clinical trial matching software, patient recruitment software and medical image analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI) in clinical trials research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in clinical trials market statistics, including the artificial intelligence (AI) in clinical trials industry's global market size, regional shares, competitors with an artificial intelligence (AI) in clinical trials market share, detailed artificial intelligence (AI) in clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in clinical trials industry. This artificial intelligence (AI) in clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Artificial Intelligence (AI) In Clinical Trials Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.95 billion
Revenue Forecast In 2033 $4.86 billion
Growth Rate CAGR of 25.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Medable Inc.; PathAI inc.; Saama Technologies Inc.; Apellis Pharmaceuticals Inc.; TriNetX LLC; SymphonyAI Summit Inc.; Aktana; Nference Inc.; Insilico Medicine Inc.; Vineti Inc.; Innoplexus AG; Healx; AiCure Inc.; MEDIAN Technologies SA; Owkin Inc.; Science 37; Ardigen SA; Cyft Inc.; Unlearn.AI Inc.; Mendel AI; Deep Lens Inc.; Antidote Technologies Inc.; Arterys Inc.; Euretos BV; Halo Health Systems Inc.; Trials.Ai Inc.; Transparency Life Sciences; BioAge Labs Inc.; Wave Life Sciences Ltd.; BioSymetrics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Artificial Intelligence (AI) In Clinical Trials Market Characteristics

    3. Artificial Intelligence (AI) In Clinical Trials Market Trends And Strategies

    4. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Artificial Intelligence (AI) In Clinical Trials Market Size and Growth

    5.1. Global Artificial Intelligence (AI) In Clinical Trials Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Artificial Intelligence (AI) In Clinical Trials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Artificial Intelligence (AI) In Clinical Trials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Artificial Intelligence (AI) In Clinical Trials Market Segmentation

    6.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Software

    Services

    6.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Trial Design

    Patient Selection

    Site Selection

    Patient Monitoring

    6.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Neurological Disease And Condition

    Cardiovascular Disease

    Metabolic Disease

    Infectious Disease

    Immunology Disease

    Other Applications

    6.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pharmaceutical And Biotechnology Company

    Contract Research Organizations

    Other End-Users

    7. Artificial Intelligence (AI) In Clinical Trials Market Regional And Country Analysis

    7.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market

    8.1. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Artificial Intelligence (AI) In Clinical Trials Market

    9.1. China Artificial Intelligence (AI) In Clinical Trials Market Overview

    9.2. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Artificial Intelligence (AI) In Clinical Trials Market

    10.1. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Artificial Intelligence (AI) In Clinical Trials Market

    11.1. Japan Artificial Intelligence (AI) In Clinical Trials Market Overview

    11.2. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Artificial Intelligence (AI) In Clinical Trials Market

    12.1. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Artificial Intelligence (AI) In Clinical Trials Market

    13.1. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Artificial Intelligence (AI) In Clinical Trials Market

    14.1. South Korea Artificial Intelligence (AI) In Clinical Trials Market Overview

    14.2. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Artificial Intelligence (AI) In Clinical Trials Market

    15.1. Western Europe Artificial Intelligence (AI) In Clinical Trials Market Overview

    15.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Artificial Intelligence (AI) In Clinical Trials Market

    16.1. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Artificial Intelligence (AI) In Clinical Trials Market

    17.1. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Artificial Intelligence (AI) In Clinical Trials Market

    18.5. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Artificial Intelligence (AI) In Clinical Trials Market

    19.9. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Artificial Intelligence (AI) In Clinical Trials Market

    20.13. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market

    21.1. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market Overview

    21.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Artificial Intelligence (AI) In Clinical Trials Market

    22.1. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Artificial Intelligence (AI) In Clinical Trials Market

    23.1. North America Artificial Intelligence (AI) In Clinical Trials Market Overview

    23.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Artificial Intelligence (AI) In Clinical Trials Market

    24.1. USA Artificial Intelligence (AI) In Clinical Trials Market Overview

    24.2. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Artificial Intelligence (AI) In Clinical Trials Market

    25.1. Canada Artificial Intelligence (AI) In Clinical Trials Market Overview

    25.2. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Artificial Intelligence (AI) In Clinical Trials Market

    26.1. South America Artificial Intelligence (AI) In Clinical Trials Market Overview

    26.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Artificial Intelligence (AI) In Clinical Trials Market

    27.1. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Artificial Intelligence (AI) In Clinical Trials Market

    28.1. Middle East Artificial Intelligence (AI) In Clinical Trials Market Overview

    28.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Artificial Intelligence (AI) In Clinical Trials Market

    29.1. Africa Artificial Intelligence (AI) In Clinical Trials Market Overview

    29.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape And Company Profiles

    30.1. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape

    30.2. Artificial Intelligence (AI) In Clinical Trials Market Company Profiles

    30.2.1. Medable Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. PathAI inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Saama Technologies Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Apellis Pharmaceuticals Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. TriNetX LLC

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Artificial Intelligence (AI) In Clinical Trials Market Other Major And Innovative Companies

    31.1. SymphonyAI Summit Inc.

    31.2. Aktana

    31.3. Nference Inc.

    31.4. Insilico Medicine Inc.

    31.5. Vineti Inc.

    31.6. Innoplexus AG

    31.7. Healx

    31.8. AiCure Inc.

    31.9. MEDIAN Technologies SA

    31.10. Owkin Inc.

    31.11. Science 37

    31.12. Ardigen SA

    31.13. Cyft Inc.

    31.14. Unlearn.AI Inc.

    31.15. Mendel AI

    32. Global Artificial Intelligence (AI) In Clinical Trials Market Competitive Benchmarking

    33. Global Artificial Intelligence (AI) In Clinical Trials Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Clinical Trials Market

    35. Artificial Intelligence (AI) In Clinical Trials Market Future Outlook and Potential Analysis

    35.1 Artificial Intelligence (AI) In Clinical Trials Market In 2028 - Countries Offering Most New Opportunities

    35.2 Artificial Intelligence (AI) In Clinical Trials Market In 2028 - Segments Offering Most New Opportunities

    35.3 Artificial Intelligence (AI) In Clinical Trials Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Medable Inc. Financial Performance
  • Table 76: PathAI inc. Financial Performance
  • Table 77: Saama Technologies Inc. Financial Performance
  • Table 78: Apellis Pharmaceuticals Inc. Financial Performance
  • Table 79: TriNetX LLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Medable Inc. Financial Performance
  • Figure 76: PathAI inc. Financial Performance
  • Figure 77: Saama Technologies Inc. Financial Performance
  • Figure 78: Apellis Pharmaceuticals Inc. Financial Performance
  • Figure 79: TriNetX LLC Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the artificial intelligence (AI) in clinical trials market?

Artificial intelligence in clinical trials refers to using artificial intelligence to design more efficient and adequate clinical trials. Artificial intelligence is used in clinical trials to improve trial design and optimization through predictions about patient behavior and drug efficacy. For further insights on the artificial intelligence (AI) in clinical trials market, request a sample here

How will the artificial intelligence (AI) in clinical trials market drivers and restraints affect the artificial intelligence (AI) in clinical trials market dynamics? What forces will shape the artificial intelligence (AI) in clinical trials industry goin

The artificial intelligence (AI) in clinical trials market major growth driver - Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth. For further insights on the artificial intelli request a sample here

What is the forecast market size or the forecast market value of the artificial intelligence (AI) in clinical trials market?

The artificial intelligence (AI) in clinical trials market size has grown exponentially in recent years. It will grow from $1.52 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches. The artificial intelligence (AI) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $4.86 billion in 2028 at a compound annual growth rate (CAGR) of 25.6%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (nlp) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes. For further insights on the artificial intelligence (AI) in clinical trials market, request a sample here

How is the artificial intelligence (AI) in clinical trials market segmented?

The artificial intelligence (AI) in clinical trials market is segmented
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-UsersFor further insights on the artificial intelligence (AI) in clinical trials market,
request a sample here

Which region has the largest share of the artificial intelligence (AI) in clinical trials market? What are the other regions covered in the report?

North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the artificial intelligence (AI) in clinical trials market, request a sample here.

Who are the major players in the artificial intelligence (AI) in clinical trials market?

Major companies operating in the artificial intelligence (AI) in clinical trials market report are Medable Inc., PathAI inc., Saama Technologies Inc., Apellis Pharmaceuticals Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc. For further insights on the artificial intelligence (AI) in clinical trials market, request a sample here.

What are the key trends in the artificial intelligence (AI) in clinical trials market?

Major trend in the artificial intelligence (AI) in clinical trials market - Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market. For further insights on the artificial intelligence (AI) in clinical trials market, request a sample here.

What are the major opportunities in the artificial intelligence (AI) in clinical trials market? What are the strategies for the artificial intelligence (AI) in clinical trials market?

For detailed insights on the major opportunities and strategies in the artificial intelligence (AI) in clinical trials market, request a sample here.

How does the artificial intelligence (AI) in clinical trials market relate to the overall economy and other similar markets?

For detailed insights on artificial intelligence (AI) in clinical trials market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the artificial intelligence (AI) in clinical trials industry?

For detailed insights on the mergers and acquisitions in the artificial intelligence (AI) in clinical trials industry, request a sample here.

What are the key dynamics influencing the artificial intelligence (AI) in clinical trials market growth? SWOT analysis of the artificial intelligence (AI) in clinical trials market.

For detailed insights on the key dynamics influencing the artificial intelligence (AI) in clinical trials market growth and SWOT analysis of the artificial intelligence (AI) in clinical trials industry, request a sample here.